Grove Instruments, a Worcester-based medical device company, announced on October 15, 2013, that it has closed its Series B-2 round of financing. Grove Instruments is a Massachusetts Life Sciences Center portfolio company, as a 2011 Accelerator Loan recipient.
Olaris is a precision diagnostics company that is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging their CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, they are able to harness the power of the body’s own communication system to discover and develop their pipeline of myOLARIS precision diagnostics.
